Last reviewed · How we verify
PROFLAVINE
At a glance
| Generic name | PROFLAVINE |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effectiveness and Performance of an Optical Biopsy Technology for Esophageal Cancer in Brazil and the United States (PHASE2)
- Precision Optical Guidance for Oral Biopsy (NA)
- Wide-Field and High Resolution In Vivo Imaging in Visualizing Lesions in Patients With Oral Neoplasia Undergoing Surgery (NA)
- Evaluation of Two Non-Invasive Methods, High-Resolution Microendoscopy and Liquid-Based Cytology, for Detection of Oral Precancer (NA)
- Multimodal Imaging for Surveillance in Patients With Oral Potentially Malignant Disorders (EARLY_PHASE1)
- The Effectiveness of High Resolution Microendoscopy for People Living With HIV (PHASE1, PHASE2)
- Low-Cost Imaging for Cervical Cancer Prevention in the Texas Lower Rio Grande Valley (EARLY_PHASE1)
- Use of High-Resolution Microendoscopy (HRME) in Patients With Adenocarcinoma In-Situ (AIS) of the Cervix (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PROFLAVINE CI brief — competitive landscape report
- PROFLAVINE updates RSS · CI watch RSS